replication-competent hsv-1 oncolytic virus
Biologicalexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2014 (NCT02272855)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- replication-competent hsv-1 oncolytic virus
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02272855 | Phase 2 | Oct 1, 2014 | Takara Bio Inc., Theradex, University of Utah |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Takara Bio Inc. | For profit | 1 | 1 | 1 | 2014 |
| Theradex | For profit | 1 | 0 | 1 | 2014 |
| University of Utah | Academic/Hospital | 1 | 0 | 1 | 2014 |
3 organizations
Page 1 / 1